Alexion Pharmaceuticals (ALXN) PT Raised to $149 at Wedbush
Wedbush analyst Laura Chico raised the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $149.00 (from $146.00) while maintaining a Outperform rating.
Wedbush analyst Laura Chico raised the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $149.00 (from $146.00) while maintaining a Outperform rating.